Yingying Wang

机构：Gansu Provincial Maternal and Child Health Hospital, Lanzhou University Second Hospital, Lanzhou University · ORCID：0009-0004-9713-3180

发表论文 68 篇 · 总被引 921 次 · h-index 19

代表论文

• The clinical effects of inclisiran, a first-in-class LDL-C lowering siRNA therapy, on the LDL-C levels in Chinese patients with hypercholesterolemia (2023 · Journal of clinical lipidology · 被引 34)
• Weierning, a Chinese patent medicine, improves chronic atrophic gastritis with intestinal metaplasia (2023 · Journal of Ethnopharmacology · 被引 27)
• A time-resolved fluorescent microsphere-lateral flow immunoassay strip assay with image visual analysis for quantitative detection of Helicobacter pylori in saliva (2023 · Talanta · 被引 26)
• An orally administered bacterial membrane protein nanodrug ameliorates doxorubicin cardiotoxicity through alleviating impaired intestinal barrier (2024 · Bioactive Materials · 被引 19)
• Circulating cardiac MicroRNAs safeguard against dilated cardiomyopathy (2023 · Clinical and Translational Medicine · 被引 16)
• Reducing complications of femoral neck fracture management: a retrospective study on the application of multidisciplinary team (2023 · BMC Musculoskeletal Disorders · 被引 14)